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Purpose: Transferrin (Tf) expression is enhanced by aging and inflammation in humans. We investigated the role of
transferrin in glial protection.
Methods: We generated transgenic mice (Tg) carrying the complete human transferrin gene on a C57Bl/6J genetic
background. We studied human (hTf) and mouse (mTf) transferrin localization in Tg and wild-type (WT) C57Bl/6J mice
using immunochemistry with specific antibodies. Müller glial (MG) cells were cultured from explants and characterized
using cellular retinaldehyde binding protein (CRALBP) and vimentin antibodies. They were further subcultured for study.
We incubated cells with FeCl3-nitrilotriacetate to test for the iron-induced stress response; viability was determined by
direct counting and measurement of lactate dehydrogenase (LDH) activity. Tf expression was determined by reverse
transcriptase-quantitative PCR with human- or mouse-specific probes. hTf and mTf in the medium were assayed by ELISA
or radioimmunoassay (RIA), respectively.
Results: mTf was mainly localized in retinal pigment epithelium and ganglion cell layers in retina sections of both mouse
lines. hTf was abundant in MG cells. The distribution of mTf and hTf mRNA was consistent with these findings. mTf
and hTf were secreted into the medium of MG cell primary cultures. Cells from Tg mice secreted hTf at a particularly
high level. However, both WT and Tg cell cultures lose their ability to secrete Tf after a few passages. Tg MG cells
secreting hTf were more resistant to iron-induced stress toxicity than those no longer secreted hTf. Similarly, exogenous
human apo-Tf, but not human holo-Tf, conferred resistance to iron-induced stress on MG cells from WT mice.
Conclusions: hTf localization in MG cells from Tg mice was reminiscent of that reported for aged human retina and age-
related macular degeneration, both conditions associated with iron deposition. The role of hTf in protection against toxicity
in Tg MG cells probably involves an adaptive mechanism developed in neural retina to control iron-induced stress.
All cells require iron for survival and as a cofactor for a
variety of enzymes [1]. However, iron is also highly toxic due
to its ability to generate free radicals via the Fenton reaction.
Homeostatic mechanisms maintain iron levels by regulation
of the proteins involved in iron import, storage, and export,
thus preventing deleterious consequences of either iron
overload or deficiency.
Diseases such as aceruloplasminemia and age-related
macular degeneration (AMD) and conditions such as siderosis
bulbi and subretinal hemorrhage are associated with increased
intraocular iron levels, contributing to subsequent retinal
degeneration [2–7]. The eye is particularly iron-dependent.
For instance, the extensive membrane biogenesis necessary to
replenish shed photoreceptor outer segments (OS) requires
iron as an essential cofactor [8]. Isomerization of all-trans-
retinal within the retinal pigment epithelium (RPE) in the
visual cycle requires iron for activation of RPE65, an enzyme
involved in the visual cycle pathway [9]. Moreover, being part
of the blood-retinal barrier, the RPE regulates the flow of iron
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and other nutrients between the choroidal vasculature and the
outer retina. The highest levels of iron are found in the
choroid, RPE, and photoreceptor inner segments (IS) and OS
in normal adult rat and human retina [10–12]. Accumulation
of iron has been observed in Royal College of Surgeons (RCS)
rats, in which phagocytosis of OS by RPE is impaired [13],
and in ceruloplasmin and hephaestin double knockout mice
[14]. The study of the roles of iron-handling proteins in the
retina will allow the normal mechanisms of iron detoxification
to be understood.
The major pathway for iron import involves the binding
of transferrin (Tf) to its receptor on the cell surface and
subsequent endocytosis. Tf is an extracellular protein, binding
and transferring iron within and across tissues. It is a
ubiquitous protein with a crucial role in iron transport and iron
homeostasis [15,16]. This protein is found in the biologic
fluids of vertebrates, mainly synthesized in hepatocytes [17],
and secreted into the blood. In adults, Tf synthesis is also
found in other cell types including oligodendrocytes [18],
choroid plexus epithelial [19], Sertoli [20], mammary
epithelial [21], and retinal cells (including RPE) [10]. Tf may
protect the retina from the potentially toxic effects of unbound
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iron; indeed, iron bound to Tf does not cause oxidative stress.
Finally, Tf seems to be essential for proliferation-promoting
activity of non-neuronal cells and survival of neuronal cells
[22,23].
We used a transgenic mouse (Tg) carrying the complete
human transferrin (hTf) gene to study the protective effect of
Tf against oxidative stress. In Tg mice, hTf mRNA has been
found in hepatocytes, oligodendrocytes, and Sertoli cells of
the testis [24]. In testis and brain, mouse Tf (mTf) is
upregulated when compared to control mice. It has been
shown that myelination and maturation of oligodendrocytes
in Tg mice induce behavioral improvements [25,26]. Sixteen-
month-old Tg mice have low testicular sperm reserves without
consequence on fertility [27].
In the present work, we first examined the retinal
distribution of hTf and mTf in Tg mice and found that hTf is
produced in RPE and Müller glial (MG) cells. Second, we
isolated and cultured MG cells from Tg and wild-type (WT)
mice and examined the potential role of hTf over-production
in protecting Tg MG cells exposed to FeCl3-nitrilotriacetate
(FeCl3-NTA). Finally, we compared its action to the effects
of exogenous human apo-Tf and holo-Tf on MG cells from
WT mice.
METHODS
Animals: Tg mice carrying the long hTf gene (80 kb)
comprising its long 5′- and 3′-regulatory sequences [24] were
generated from the 803 line previously described [26]
backcrossed in the C57Bl/6J background. They were screened
for the presence of hTf in the blood, using ELISA. All Tg mice
used in this study were homozygous for the hTf gene. Control
animals were WT C57Bl/6J mice (Janvier, Le Genest, St. Isle,
France). All mice were fed a standard laboratory diet and tap
water ad libitum and maintained in a temperature controlled
room at 21–23 °C with a 12h:12h light-dark photoperiod.
Experimental procedures were performed in accordance with
the Association for Research in Vision and Ophthalmology
(ARVO) statement for the use of animals in ophthalmology
and vision research and were approved by each author's
institutional animal care review board.
Immunohistofluorescence analysis: Freshly enucleated eyes
from one-month-old WT and Tg mice were fixed by
incubation in 4% paraformaldehyde (Inland Europe, Conflans
sur Lanterne, France) in 1X phosphate-buffered saline (PBS,
Gibco distributed by Invitrogen, Cergy Pontoise, France) for
2 h, then mounted in Tissue Tek O.C.T. (Siemens Medical,
Puteaux, France) and frozen with dry ice. Next, 10 µm frozen
sections were cut on a Leica CM3050S freezing microtome
(Leica, Rueil Malmaison, France). Sections were incubated
for 1 h with primary antibodies diluted in PBS, as follows:
1:100 rabbit polyclonal anti-mTf (Florian Guillou, INRA,
France) [28], 1:100 rabbit polyclonal anti-hTf (Florian
Guillou) [29], and 1:250 rabbit anticellular retinaldehyde
binding protein (CRALBP; received as a gift from John Saari,
University of Washington, Seattle, WA). Control sections
were incubated with non-immune rabbit serum (Invitrogen,
Cergy Pontoise, France). For CRALBP antibody, sections
were first blocked with 1% BSA (Sigma, Saint Quentin
Fallavier, France) and 10% normal goat serum (Invitrogen)
before incubation with the primary antibody. An eye from a
90-year-old man (gift from Monica Valtink, Uni-Augenklinik
Dresden, University Eye Hospital, Dresden, Germany) was
mounted, cut, and examined using the aforedescribed
procedure, for the presence of hTf.
Sections were washed with PBS and then incubated for 1
h with secondary antibodies (goat antirabbit) labeled with
Texas Red (Jackson Laboratories distributed by TebuBio, Le
Perray en Yvelines, France), Alexa 596, or Alexa 488
(Invitrogen).
Nuclei were counterstained with 4’,6-diamidino-2-
phenyl-indole (Sigma). Sections were analyzed by
fluorescence microscopy using a Leica Aristoplan and
photographed with a Spot camera (Optilas, Evry, France),
using identical exposure parameters across samples to be
compared.
Preparation of retinal extracts: Retinal extracts were obtained
by incubating 5 mg retinal tissue, obtained from one-month-
old WT and Tg mice in lysis buffer. The buffer was composed
of 15 mM Tris, pH 7.9, 60 mM KCl, 15 mM NaCl, 2 mM
EDTA, and 0.4 mM phenylmethylsulphonyl fluoride (Perbio
Science, Brebiers, France). After four successive freeze–thaw
cycles (liquid nitrogen-room temperature), lysates were
centrifuged at 5,000x g for 10 min, and supernatants were
stored at –20 °C. hTf and mTf were measured in equal
TABLE 1. OVERVIEW OF ALL PRIMERS USED IN THE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION.
Gene name Forward primer (5′-3′) Reverse primer (5′-3′) References







Forward and reverse primers sequences used to detect mouse and human transferrin and mouse beta actin genes with the reverse
transcriptase polymerase chain reaction method.
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volumes of supernatant by ELISA and radioimmunoassay
(RIA), respectively. Results were reported in ng/ml of
supernatant.
Transferrin quantification: hTf and mTf from retinal extracts
of WT and Tg mice were quantified by an antibody-sandwich
ELISA, as previously described [29]. The microtitration plate
was coated with rabbit anti-hTf (Florian Guillou), then
different concentrations of hTf (Sigma) or samples to be
quantified were added. The plate was incubated with sheep
anti-hTf (Invitrogen) and with a peroxydase-conjugated-anti-
sheep-immunoglobin (Sigma). Enzyme activity was
determined using alpha-phenylenediamine (Sigma) as
substrate and absorbance was read at 492 nm. The minimun
limit for detection was 0.1 ng/ml. The cross-reaction rate for
hTf antibodies with mTf was less than 0.05%. mTf was
measured by RIA, as previously described [28]. RIA was set
up using 125I-labeled-mTf. The minimun limit for detection
was 1 ng/ml. The cross-reaction rate for mTf antibodies with
hTf was less than 0.0001%. All standards and samples were
assayed in triplicate. The cross-reaction rate for mTf
antibodies with hTf was less than 0.0001%.
Human transferrin and mouse transferin analysis by RT-
qPCR: Eyes from one-month-old WT and Tg mice were
enucleated, and retinas were completely dissected and
homogenized using a pellet pestle motor (Dutscher, Issy les
Moulineaux, France) in lysis buffer and frozen at −80 °C after
centrifugation. Lysates were thawed and RNA isolated using
an RNeasy mini kit column (Qiagen, Courtaboeuf, France).
First strand cDNA was obtained by standard reverse
transcriptase (RT) reaction (Invitrogen). Next, 150 ng RNA
was reverse transcribed for 50 min at 42 °C with 200 U
SuperScript II Reverse Transcriptase (Invitrogen) and
oligod(T). One µl of Rnase H was added to each sample and
incubated for 20 min at 37 °C before target cDNA
amplification. A qPCR mastermix was prepared to a final
volume as indicated: 7.5 µl water, 0.1 µl mixed forward and
reverse primers (0.25 µM each; MWG Biotech Fr, Champlan,
France), 0.4 µl Rox Reference Dye, and 10 µl Platinum SYBR
Green qPCR Super-Mix-UDG (Invitrogen). Next, 18 µl
aliquots were each added to 2 µl of cDNA (1:10 dilution) in
a reaction plate (Applied Biosystems, Applera France SA,
Courtaboeuf, France) . Please see Table 1 for detailed
information about primers.
Amplification was performed using an Applied
Biosystems 7300 Real-Time PCR System. The following
conditions were used: 95 °C for 10 min (denaturation); 40
cycles of 95 °C for 15 s and 60 °C for 1 min (amplification
and quantification); and 95 °C for 15 s, 60 °C for 30 s, and
95 °C for 15 s (melting curve). Crossing points (CP) for each
transcript—the point at which the fluorescence is significantly
higher than background fluorescence—were determined for
subsequent analysis.
Cell cultures: Four or five WT or Tg mice were killed between
postnatal day 8 and 12 (PN8–12) by decapitation. Next, eyes
were rapidly enucleated, transferred into Dulbecco’s
Modified Eagle Medium (DMEM; Invitrogen), and stored
overnight at room temperature in the dark. Intact globes were
then incubated in DMEM containing 2 mg/ml trypsin 250
(Invitrogen) and 2 mg/ml collagenase Type I (Worthington,
Coger, Paris, France) at 37 °C for 60 min. Globes were placed
in a Petri dish containing DMEM supplemented with 10%
fetal calf serum (FCS; Invitrogen), 1% penicillin and
streptomycin (Invitrogen), 1% L-glutamine (Invitrogen), and
0.1% fungizone (Invitrogen). Retinas were removed,
mechanically dissociated into small pieces with forceps, and
seeded into 10 cm Petri dishes, each containing approximately
between five and seven retinas. After three to four days,
medium was replaced with fresh medium. From then on,
medium was replaced every week. Pigmented eyes were used
for all experiments to monitor potential contamination by
foreign tissue, such as RPE or choroid. All cultures were
maintained at 37 °C in a humidified incubator with 5%
CO2/95% air. This is a recommended protocol for selection of
MG cells.
Enrichment of adherent cells and Müller glial cell passaging:
Once MG cells reached semiconfluence (five to seven days),
retinal aggregates and debris were removed by vigorously
pipeting medium onto the dish. This was repeated three to five
times to dislodge all aggregates. Cell cultures were split when
they were confluent. Cells were rinsed with calcium-free PBS
followed by a brief incubation in PBS containing 0.05%
trypsin-EDTA (Invitrogen). The suspension was centrifuged
at 1,000 rpm for 10 min, cell pellets were resuspended, and
cells were seeded at 12x103 cells/cm2 in fresh DMEM,
supplemented with 10% FCS, 1% penicillin and streptomycin,
1% L-glutamine, and 0.1% fungizone.
Müller glial cell immunocytochemistry: The homogeneity of
cell cultures from WT and Tg mice was evaluated by
immunocytochemistry with the specific MG cell marker,
vimentin. Subcellular localization of mTf and hTf was
determined using specific antibodies. First passage MG cells
grown on LabTek chamber slides (VWR International,
Strasbourg, France) were washed twice with PBS and fixed
with 4% paraformaldehyde for 15 min. Cells were
permeabilized with 0.1% Triton X-100 in PBS for 10 min and
blocked with 1% BSA solution for 30 min. Primary
antibodies; rabbit anti-mTf, rabbit polyclonal anti-hTf, and
rabbit antivimentin were each diluted in PBS containing 0.5%
BSA. As per the aforedescribed procedure, MG cells were
treated with secondary antibodies for retinal sections.
Exposure of cells to iron: MG cells from WT and Tg mice
were incubated with 1:4 freshly prepared FeCl3-NTA solution
(François Canonne-Hergaux, Bichat, France). NTA is a small
molecular weight chelator, sequestering Fe3+ and forming
hydrophobic complexes [30]. Cells were seeded at a density
of 12x103 cells/cm2 in 24 or 12 well plates and incubated in
DMEM containing 10% FCS, 1% penicillin and streptomycin,
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Figure 1. Human transferrin is localized in the same cells in transgenic mice retina as in human retina. A: Non-immune serum was used as a
control. B-D: Human transferrin (hTf; green) localization was realized on frozen sections of one-month-old transgenic (Tg) mice retina. hTf
is localized in Müller glial (MG) cells and retinal pigment epithelium (RPE; B,C), identified with cellular retinaldehyde binding protein
(CRALBP; red; D), specific marker. C: Higher magnification of RPE from (B). E-F: hTf is localized in a 90-year-old human retina (E) in the
same cells as in Tg mice still identified by CRALBP (F). The following abbreviations are used: Ganglion cell layer (GCL), inner nuclear layer
(INL), inner plexifrom layer (IPL), inner segments (IS), outer limiting membrane (OLM), outer nuclear layer (ONL), outer plexifrom layer
(OPL), outer segments (OS), retinal pigmented epithelium (RPE). The scale bars in A,B, D-F equal 100 µM and the scale bar in C equals 10
µm.
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1% L-glutamine, and 0.1% fungizone. Cells were counted
when they were confluent (after three days). Cells were
washed in PBS and incubated in serum-free medium
containing FeCl3-NTA at a final concentration of 100 µM or
500 µM for 96 h. Cells incubated in medium without FeCl3-
NTA served as controls.
Figure 2. Mouse transferrin is synthetized and localized in one-month-old mouse retina. A: Non-immune serum was used as a control. B-C:
Mouse transferrin (mTf; green) is localized on frozen sections of wild-type (WT) mice (A,B) and in transgenic (Tg) mice (C). Scale bar equals
100 µM. The following abbreviations are used: Ganglion cell layer (GCL), inner nuclear layer (INL), inner plexifrom layer (IPL), inner
segments (IS), outer limiting membrane (OLM), outer nuclear layer (ONL), outer plexifrom layer (OPL), outer segments (OS), retinal
capillaries (RC), retinal pigmented epithelium (RPE). D: mTf concentration (ng/ml) was measured by radioimmunoassay (RIA) in supernatant
of retinal extracts of WT and Tg mice . Each column represents the mean ±SEM. The double asterisk represents statistical significance of
differences from control, p<0.01. E: mTf mRNA expression was quantified by RT-qPCR in retinal extracts from WT and Tg mice. Each
column represents the mean ±SEM. The asterisk represents statistical significance of differences from control, p<0.05.
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Exogenous human transferrin treatment: MG cells from WT
mice were treated with exogenous human apo and holo-Tf
(Sigma). As per the aforedescribed protocol, first passage MG
cells were prepared, before iron exposure. Cells were
incubated for 96 h in serum-free medium containing 100 µM
FeCl3-NTA with freshly prepared hTf solution added to final
concentrations of 2.5, 5, 10, and 20 ng/ml. Incubations with
the four hTf concentrations but without FeCl3-NTA were also
performed. For quantification purposes, cell counts for
cultures incubated without FeCl3-NTA were defined as 100%.
Cell number evaluation: Cells were counted using a Malassez
cell. After treatment, cells were removed from plates as
described in the next section. Cell pellets were resuspended
in DMEM containing 10% FCS. Suspension aliquots were
placed in a Malassez cell, and cells were counted under an
inverted microscope DMIRB (Leica) equipped with phase
contrast. Results, normalized to the volume of the cell
suspension, were expressed as percentages ±standard error of
MG cells under control conditions (without 100 µM FeCl3-
NTA), for WT and Tg mice.
Determination of cell viability: Cell viability was determined
by measuring lactate dehydrogenase (LDH) activity in the
incubation medium with a microtiter plate assay (Nunc
distributed by VWR International). Next, 100 µl aliquots of
incubation medium were collected following iron stress and
incubated with 100 µl of Cytotoxicity Detection Kit reaction
mixture (Roche Diagnostics, Meylan, France) for 30 min at
room temperature in the dark. The optical density of the
solution was measured on an ELISA plate reader with 492 and
620 nm filters (Benchmark Plus microplate
spectrophotometer, BioRad, Marnes-la-Coquettes, France).
LDH activity in the incubation medium was compared with
that measured after complete lysis of the cells in medium
containing 2% Triton X-100. A viability percentage of zero
corresponded to 100% LDH activity in the medium.
Transferrin quantification and RT-qPCR analysis of human
transferrin and mouse transferrin: hTf and mTf were
measured by ELISA and RIA, respectively, in MG cell
medium and in MG cells (from WT and Tg mice) following
iron stress treatment, according to the method described for
hTf and mTf retinal extract measurements.
For RT-qPCR analysis, MG cells, treated with or without
iron, were lysed in buffer and lysates were frozen at −80 °C.
Methods used were as described in the previous section for
RT-qPCR analysis of retinal extracts.
Statistical analysis: Results were presented as mean
±standard error of the mean. We used the Mann–Whitney U-
test to evaluate differences between Tg and WT mice.
Analysis was performed using GraphPad Prism 4 software. A
p<0.05 was considered statistically significant. Each
experimental condition was repeated three or four times, and
MG cells used were from different primary cell cultures.
RESULTS
Characterization of transgenic mice and detection of
transferrin protein and mRNA: hTf protein was detected in Tg
mouse retina by immunohistochemistry. hTf was observed in
the RPE layer and MG cells identified by CRALBP
immunoreactivity, a specific marker for MG cells (Figure 1B,
D). hTf was present in MG cell bodies within the inner nuclear
layer and in MG cell processes that form radial extensions
through the retina. hTf in human retina sections had the same
distribution (Figure 1E-F). These findings were confirmed by
the detection of hTf protein and mRNA in Tg mouse retina by
ELISA and RT-qPCR (data not shown). hTf in Tg mouse
retina was detected at early stages of development (postnatal
day 1) and its localization pattern correlated with MG cell
differentiation during embryonic and postnatal development
(data not shown).
For both WT and Tg mice, we demonstrated that mTf
protein was present in the outer segments (OS) and, to a lesser
extent, in the inner segments (IS) of photoreceptors, in the thin
layer of RPE cells and in astrocytes of the ganglion cell layer
(GCL; Figure 2B-C). mTf immunoreactivity was also
detected in retinal capillaries, choroid, and sclera. Diffuse mTf
immunoreactivity was evident throughout both WT and Tg
mice retinas during the first days of development; mTf then
became localized to the cellular layers. The patterns of mTf
immunoreactivity in WT and Tg mice were similar throughout
development (data not shown).
mTf protein was detected in retinal extracts from both
WT and Tg mice using ELISA and RIA. However, levels of
mTf were significantly higher in Tg mouse retina than in WT
(Figure 2D). Consistent with these results, mTf mRNA was
detected in both WT and Tg mice neural retina using RT-
qPCR. mTf mRNA levels were significantly higher in Tg
mouse retina than in WT retina (Figure 2E).
Transferrin synthesis in Müller glial cells in vitro: To
investigate the role of hTf in Tg mouse retina, we isolated MG
cells from PN8–12 WT and Tg mice and cultured them as
described in methods [31]. All cells from both mouse types
were vimentin immunoreactive (vimentin is a specific marker
of MG cells) in primary cultures (Figure 3A,B) as well as in
subcultures (results not shown).
mTf and hTf protein was detected by
immunocytochemistry in MG cells from WT and Tg mice.
Both mTf and hTf were detected in the cytoplasm of MG cells
(Figure 3C-E). However, even in primary cultures, there was
some heterogeneity in the levels of protein present.
Media from primary cultures and subsequent passages of
WT and Tg MG cells were assayed for hTf and mTf by ELISA
and RIA, respectively. mTf concentration in Tg mice-derived
primary culture medium was significantly twice that in WT
mice-derived cell medium (Figure 4A). The concentration of
hTf in MG cells from Tg mice was 10 times the mTf
concentration (Figure 4B). In WT and Tg mice-derived MG
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cells, mTf and hTf concentrations significantly decreased
progressively with the number of passages, such that Tf levels
were undetectable by the third passage.
Effects of iron stress on Müller glial cell viability in culture:
To test the response of MG cells from WT and Tg mice to a
metabolic stress, MG cell cultures (passages one and three)
were treated with two concentrations of 1:4 FeCl3-NTA (100
and 500 µM) in serum-free medium. The number of MG cells
in first passage WT cultures treated with 100 µM FeCl3-NTA
was 35% lower (p<0.0007) than in untreated WT cultures.
Conversely, cell counts in Tg cultures treated with this same
concentration of FeCl3-NTA were not significantly different
from those in untreated cultures (Figure 5A). However, cell
counts in cultures treated with 500 µM of FeCl3-NTA were
less than 50% of those in untreated cultures (data not shown).
Third passage cell cultures, with barely detectable hTf and
mTf levels, treated with 100 µM FeCl3-NTA, had a 60% lower
survival rate than untreated third passage cultures (data not
shown).
LDH activity was assayed in the medium of FeCl3-NTA-
treated, first passage WT MG cells to evaluate cell death. LDH
activity was 8.6% significantly higher (p<0.002) in media
Figure 3. Mouse transferrin and human transferrin are present in
Müller glial cells from 8- to 12-day-old wild-type and transgenic
mice. A-B: Müller glial (MG) cells in culture from wild-type (WT;
A) and transgenic (Tg; B) mice were identified with vimentin
staining (red) specific marker. C-E: Mouse transferrin (mTf; C,D)
and human transferrin (hTf; E; green) were localized in MG cells
from WT (C) and Tg (D,E) mice. Scale bar: 100 µm.
from cells treated with 100 µM of FeCl3-NTA than in media
from untreated WT controls. Conversely, there was no
Figure 4. Transferrin secretion in medium of Müller glial cells from
8 to 12-day-old wild-type and transgenic mice decreases with the
subcultures. A: Mouse transferrin (mTf) secretion in medium of
cultured Müller glial (MG) cells from wild-type ( WT) and transgenic
(Tg) mice at confluency after primary culture (P0) and at the first
(P1) and the second passages (P2) was measured by
radioimmunoassay (RIA; ng/ml). Each column represents the mean
±SEM. The asterisk represents statistical significance of differences
between WT and Tg at P0, p<0.05. The triple asterisk represent
statistical significance of differences from WT and Tg mice betwen
P1 and P2 compared to P0 and between P1 and P2 themselves,
p<0.001. B: Human transferrin (hTf) secretion in medium of
cultured MG cells from WT and Tg mice at confluency after primary
culture (P0) and at the first (P1) and the second passages (P2)
was measured by ELISA assay (ng/ml). Each column represents the
mean ±SEM. The asterisk represents statistical significance of
differences from P0, p<0.05. The double asterisk represents
statistical significance of differences from WT and Tg mice
betwen P1 and P2 compared to P0 and between P1 and P2
themselves, p<0.0.1.
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significant difference between LDH activity in media of hTf
Tg-derived MG cells treated with 100 µM FeCl3-NTA and
that in untreated Tg cell media (Figure 5B).
Effects of iron stress on mouse and human transferrin
expression in Müller glial cells: MG cell culture media from
WT and Tg mice were collected after 96 h of iron stress and
mTf and hTf concentrations were measured by RIA and
ELISA. The mTf concentration in the medium of untreated
Tg-derived MG cells was significantly higher (p<0.002) than
in the medium of untreated cells from WT mice (Figure 6A).
However, there was no significant difference in mTf
concentration between cell culture media treated with and
without 100 µM of FeCl3-NTA for either WT or Tg mice.
Moreover, the hTf concentration in Tg mice MG cell culture
media was fivefold higher than mTf concentration. The hTf
concentration in the medium of Tg cells treated with 100 µM
FeCl3-NTA was 50% lower than that in untreated Tg cell
medium (Figure 6B). In cell lysates, mTf and hTf were
undetectable (data not shown).
RT-qPCR was used to determine intracellular mTf and
hTf mRNA levels WT and Tg cell cultures following 96 h of
iron stress. mTf mRNA was significantly more abundant in
MG cells from Tg mice than in those from WT mice, whether
treated or untreated (Figure 7A). MG cells from WT mice
treated with 100 µM of FeCl3-NTA had a significantly
(p<0.002) lower level of mTf mRNA expression than
untreated WT cells, whereas there was no significant
difference between treated and untreated cells from Tg mice.
However, Tg cells treated with 100 µM FeCl3-NTA had
significantly lower (p<0.002) hTf mRNA levels than
untreated Tg cells (Figure 7B).
Addition of exogenous human transferrin in medium of Müller
glial cells from wild-type mice after iron stress: We added 2.5,
5, 10, and 20 ng/ml commercial human apo-Tf to WT MG cell
culture media containing 100 µM of FeCl3-NTA to investigate
the potential protective effect of human apo-Tf on WT MG
cells. Addition of only exogenous human apo-Tf had no effect
on MG cell numbers, even at the highest concentrations (data
not shown). However, cells treated with 100 µM of FeCl3-
NTA and 2.5 ng/ml human apo-Tf had a significantly higher
survival rate (92%) than iron-treated cells without addition of
exogenous human apo-Tf (70%). Cells with 5, 10, and 20 ng/
ml of human apo-Tf added to medium containing 100 µM of
FeCl3-NTA had survival rates that were 35% to 43% higher
than those with FeCl3-NTA alone. There was no significant
difference between cells with and without exogenous human
apo-Tf in the absence of iron (Figure 8). To compare the
protective effects of human apo-Tf on WT MG cells, we also
added 2.5, 5, 10, and 20 ng/ml commercial human holo-Tf to
WT MG cell culture media containing 100 µM of FeCl3-NTA.
Addition of exogenous human holo-Tf alone at the
concentration of 2.5 ng/ml had no significative effect on MG
cell numbers. At the highest concentrations (10 and 20 ng/ml),
human holo-Tf alone diminished significantly the number of
cells compared to condition without iron added (Figure 9A).
Cells treated with 100 µM of FeCl3-NTA and 2.5 and 5 ng/ml
Figure 5. Müller glial cells from transgenic mice are more resistant
to iron-mediated stress than Müller glial cells from wild-type mice.
A: Culture of Müller glial (MG) cells from wild-type (WT) and
transgenic (Tg) mice at the first passage were treated with 100 µM
of FeCl3-NTA (FN), during 96 h. The number of cells was evaluated
by counting in comparison to control condition. Each column
represents the mean ±SEM. The triple asterisk represent statistical
significance of differences between treated and control, respectively,
for WT and Tg, and between control and treated, p<0.001. B: Release
of lactate dehydrogenase (LDH) was measured after incubation of
MG cells with 100 µM of FN. The percent (%) release of LDH from
MG cells was reported to the total LDH release. Each column
represents the mean ±SEM. The double asterisk represents statistical
significance of differences from control, p<0.01 In both figures, data
considered not significant is marked NS.
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human holo-Tf had a significantly higher survival rate (98 and
83%) than iron-treated cells without addition of exogenous
human holo-Tf (70%). Nevertheless, 10 and 20 ng/ml human
holo-Tf added to media with 100 µM of FeCl3-NTA had no
significative effect on survival rate (Figure 9B) compared to
iron-treated cells.
DISCUSSION
Iron is an essential component of cell survival [1], but its
capacity to generate highly reactive hydroxyl free radicals via
the Fenton reaction can also render it toxic to cells. Iron
accumulates in the retina during aging [11,12] and in some
retinal degenerative animal models [13,14]. Many proteins
such as ferritin, transferrin receptor, and transferrin are
involved in regulating iron status. Tf can transport two ferric
ions per molecule across the cell membrane, rendering it
protective against toxic effects of labile iron. We investigated
the regulation of Tf levels in WT and Tg mice. The 16 months-
old Tg mice have an apparently normal phenotype, although
they have low testicular sperm reserves that do not affect
fertility [27]. Retinal structure was not affected and mTf
localization was similar in WT and Tg mice in the RPE cell
layer, photoreceptor layer, and ganglion cell layer. This same
pattern of localization has been described in rat retina [10].
However, in Tg mice, most hTf was in MG and RPE cells,
identified using specific markers. This pattern of hTf
localization is also observed in human retina; the fact that Tg
mice express the hTf gene under the control of its own
promoter may explain this similarity [26].
Expression of hTf transgene seemed to affect endogenous
mTf production. Indeed, Tg retinal extracts contained
significantly more endogenous mTf proteins and mRNA than
WT retinal extracts in Tg mice. Similar findings have been
reported in Sertoli cells and the brain [25].
We cultured MG cells from Tg and WT mice to determine
where Tf is synthesized and transported. MG cells were
positively identified in all cultures, using vimentin as a
specific marker. hTf immunoreactivity was detected in the
cytoplasm of MG cells from Tg mice and in the culture
medium. mTf was also detected in the cytoplasm and media
of both WT and Tg MG cells. mTf production may be
activated in these cells as a stress response caused by culture.
In retina from diabetic rats, MG cells upregulate many genes
associated with inflammation including Tf [32].
MG cells synthesize and secrete mTf and hTf but lose this
ability as the number of passages increase, suggesting that hTf
and endogenous mTf promoters have similar activities and are
similarly regulated. mTf and hTf promotors both contain the
cis-acting regulatory elements PRI and PRII, which are
similar in the two species [33]. The proximal promoter regions
of both hTf and mTf contain a CCAAT consensus sequence
that binds to members of the CAAT enhancer-binding protein
family of transcription factors [34].
Despite these similarities, there was some discrepancy in
Figure 6. Mouse transferrin and human transferrin proteins
expression are modulated after iron stress. A: Mouse transferrin
(mTf) secretion was measured by radioimmunoassay (RIA) in the
culture medium of Müller glial (MG) cells from wild-type (WT) and
transgenic (Tg) mice in control condition or after addition of 100 µM
of FeCl3-NTA (FN) during 96 h. Each column represents the mean
±SEM. The double asterisk represents statistical significance of
differences between treated and control, respectively, for WT and
Tg, p<0.01. B: Human transferrin (hTf) secreted was quantified by
ELISA assay in the culture medium of MG cells from Tg mice in
control condition or after addition of 100 µM of FN during 96 h. Each
column represents the mean ±SEM. The double asterisk represents
statistical significance of differences from control, p<0.01 In both
figures, data considered not significant is marked NS.
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the expression of both hTf and mTf in MG cells between Tg
and WT mice, which probably corresponds to several
differences between hTf and mTf promoter sequences [35].
We observed there was significantly more hTf protein than
Figure 7. Mouse transferrin and human transferrin mRNA expression
are modified after iron stress. A: Mouse transferrin (mTf) mRNA
expression was quantified by RT-qPCR in Müller glial (MG) cells
respectively from wild-type (WT) and transgenic (Tg) mice in
control condition and after addition of 100 µM FeCl3-NTA (FN) in
the medium during 96 h. Each column represents the mean ± SEM.
The double asterisk represents statistical significance of
differences between treated and control, respectively, for WT and
Tg, and between control and treated, p<0.01. B: Human transferrin
(hTf) mRNA expression was quantified by RT-qPCR in MG cells,
respectively, from Tg mice in control condition and after addition of
100 µM FN in the medium during 96 h. Each column represents the
mean ±SEM. The double asterisk represents statistical
significance of differences from control, p<0.01 In both figures, data
considered not significant is marked NS.
mTf protein in retinal extract and culture media of MG cells
from Tg mice. Thus, mechanisms regulating hTf and mTf are
not identical in these Tg mice. Our findings of differences in
localization patterns are consistent with this. In the rat brain,
Tf mRNA is observed in oligodendrocytes [36] and epithelial
cells of the choroid plexus [18]. By contrast, Tf mRNA is not
observed in the human choroid plexus [19]. Moreover, hTf
transgene is inserted in the F1 area of the chromosome 12
[27] and the number of copies is nearly 12 (F. Guillou,
personal communication), which could explain the specificity
of expression noticed.
Tf has many functions; most are related to its Fe3+-binding
and -transporting properties, rendering it a potent antioxidant.
In renal ischemia-reperfusion injury, Tf lowers the circulating
redox-active iron levels [37]. Tf has potent anti-apoptotic/
cytoprotective effects against Fas-mediated signals in
hepatocytes and lymphohemopoietic cells [38,39]. In a rabbit
model of after-cataract formation following cataract surgery,
Tf synthesis is upregulated in lens epithelia acting as a survival
and proliferative factor [40]. These properties can be used to
prevent iron accumulation and free radical formation by the
Fenton reaction in many situations [37]. For example, ovoTf
Figure 8. Exogenous human apo-transferrin protects Müller
glial cells from wild-type mice from iron-induced stress. The Müller
glial (MG) cells from wild-type (WT) mice at the first passage were
treated with 100 µM of FeCl3-NTA (FN) in presence or absence of
different concentrations (2.5, 5, 10, and 20 ng/ml) of human apo-
transferrin (h apo-Tf). Their number was determined by counting in
comparison to control condition. Each column represents the mean
±SEM. The asterisk represents statistical significance of
differences from FN alone, p<0.05. Data considered not significant
compared to control are marked NS.
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is a survival and growth-promoting factor [41]. Tf may
function as a neurotransmitter or neuromodulator in the
developing vertebrate nervous system [42]. In addition, MG
cells mediate nerve cell protection [43–45]. Moreover, MG
cells are potential regenerative stem/precursor cells involved
in neural retina regeneration response in vertebrates following
lesion [46,47].
We subjected these cells to iron-induced stress using
NTA, increasing levels of bound and unbound iron in the
cytoplasm [46–48] without activation of the classical Tf
receptor endocytosis pathway [49,50].
We observed that treatment with 100 µM FeCl3-NTA did
not affect survival of Tg MG cells during the first passage,
whereas there were 35% fewer cells in WT cultures following
treatment with 100 µM FeCl3-NTA than there were in
untreated WT cultures. During the third passage of Tg MG
cells, hTf could no longer be detected in the medium and the
effects of iron treatment were similar in cells from both WT
and Tg mice. Cell survival correlated with hTf concentration
during the subculture. Moreover, WT MG cells treated with
human apo-Tf but not human holo-Tf were protected against
100 µM FeCl3-NTA. Unlike human holo-Tf, WT MG cells
survival against iron treatment is correlated to the capacity of
human apo-Tf to catch iron in excess. Human holo-Tf, which
probably is not fully saturated with iron, seemed to be
protective at the lowest concentrations (2.5 and 5 ng/ml). At
the highest concentrations (10 and 20 ng/ml), it seemed to be
toxic because its iron loads were higher.
We quantified the levels of Tf protein and mRNA in
serum-free medium to assess the effects of iron-induced stress
on hTf and mTf metabolism in MG cells. As expected mRNA
levels were slightly lower for mTf and markedly lower for hTf
in the presence than absence of iron. The molecular basis for
the lower levels of hTf following iron administration has not
been extensively studied. In humans, anemia resulting in iron
deficiency is associated with high plasma Tf levels whereas
conditions resulting in excess iron stores are associated with
low plasma Tf [51]. The low plasma Tf concentration
associated with increased iron stores in humans may be due
to the effects of negative feedback on Tf synthesis [52].
Tf gene transcription is induced by a variety of factors in
a tissue-specific manner. In rats and chickens, nutritional iron
deficiency activates Tf gene transcription specifically in the
liver, resulting in a several-fold increase in Tf synthesis [53,
54]. In human hepatoma HepG2 cells lines, iron treatment
suppresses Tf synthesis demonstrating regulation of intact
endogenous Tf synthesis by iron [54]. Previous studies on
transgenic mice have identified a 50 nucleotide region in the
5′UTR of hTf mRNA involved in hTf iron regulation. Within
this region, an an iron responsive element (IRE)- homologous
sequence (“the putative hTf IRE”) was identified [55].
The high level of hTf in the medium of hTf Tg MG cells
may be a protective mechanism against the labile iron pool.
Tf sequestrates iron from the FeCl3-NTA added to the
Figure 9. Exogenous human holo-transferrin does not protect Müller
glial cells from wild-type mice from iron-induced stress. A,B: The
number of Müller glial (MG) cells from wild-type (WT) mice in
culture at the first passage after treatment with 100 µM of FeCl3-
NTA (FN), during 96 h was evaluated by counting in comparison to
control condition A: The MG cells from WT mice at the first passage
were treated with different concentrations (2.5, 5, 10, and 20 ng/ml)
of human holo-transferrin (h holo-Tf). Their number was determined
by counting in comparison to control condition. Each column
represents the mean ±SEM. The asterisk represents statistical
significance of differences for treated by h holo-Tf alone in relation
respectively to control and to treated by FN alone, p<0.05 Data
considered not significant compared to control or to treated by FN
alone is marked NS. B: The MG cells from WT mice at the first
passage were treated with 100 µM of FN in presence of different
concentrations (2.5, 5, 10, and 20 ng/ml) of h holo-Tf in the medium.
Their number was determined by counting in comparison to control
condition. Each column represents the mean ±SEM. The asterisk
represents statistical significance of differences for treated by h holo-
Tf after FN in relation, respectively, to control and to treated by FN
alone, p<0.05. Data considered not significant compared to control
or to treated by FN alone is marked NS.
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medium, preventing iron toxicity. The use of FeCl3-NTA
permits direct entry of iron into the MG cells where it is stored
by ferritin. Iron excess inhibits activation of Tf transcription.
Very low levels of hTf mRNA may result from transcription
factors binding specific hTf promoter sequences. hTf can
regulate its transcription directly or indirectly in an autocrine
manner. hTf is an autocrine factor for the development and
maturation of oligodendrocytes [56]. In humans, Tf produced
by T cells can function in an autocrine manner rather than a
paracrine manner [57]. Tf synthesis in small cell lung cancer
cells also acts as an autocrine regulator of cellular
proliferation, allowing these cells to continue proliferating
under transferrin-free conditions [58].
In our study, isolated MG cells from Tg mice expressing
hTf were protected against iron-mediated stress. We believe
that hTf regulates its transcription in an autocrine manner to
control intracellular iron levels. These findings are consistent
with a potential protective role for Tf in retina, which is related
to the capacity of Tf to bind iron. Thus, therapeutic targeting
of retinal Tf may be beneficial in pathological conditions
involving iron accumulation such as aging, AMD, and
inflammation.
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